Company Analysis

Avalo Therapeutics, Inc. (AVTX)

Nasdaq: AVTX · Pharmaceutical Preparations · Wayne, PA · filing with the SEC since 2012
Grade2.6
◀ Past 1.6● Present 2.6▶ Future 3.3
1 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 23, 2026Mar 20, 2025Mar 29, 2024Mar 29, 2023Mar 2, 2022Mar 8, 2021Mar 11, 2020Mar 18, 2019Apr 2, 2018Mar 14, 2017
Revenue59,000441,0001,924,00018,051,0005,398,0006,699,000r6,750,3517,028,378r27,813,1371,152,987
Cost of revenue··1,284,0003,434,0001,491,000300,000r-566,5233,260,668r635,6480
Research and development50,084,00024,437,00013,784,00031,308,00059,835,00032,193,000r11,764,1335,786,6354,372,57810,149,879
Selling, general and administrative··10,300,00020,711,000······
Sales and marketing····2,826,0002,341,000r1,484,044545,218r569,825r0
General and administrative22,900,00017,241,00010,300,00020,711,00024,658,000r17,418,000r10,123,32010,511,207r7,941,5847,083,155
Total operating expenses·······57,640,56713,923,15517,233,034
Total costs and expenses72,984,00068,953,00029,275,00055,491,00087,532,00079,542,000r22,887,75942,406,871··
Operating income-72,925,000-68,512,000-27,351,000-37,440,000-82,134,000-72,843,000r-16,137,408-35,378,493r13,889,982-16,080,047
Interest income (expense), net4,351,0003,312,000r-3,417,000-4,170,000-2,391,00049,000r121,32616,261r-24,016-464,181
Other income (expense), net·-5,000-42,000-20,000-20,000409,000r-28,287r13,6570·
Total non-operating income (expense)-5,169,00033,497,000-4,179,000-4,190,000-2,411,0005,666,000r146,97154,928r-53,640-391,556
Income before income taxes-78,094,000-35,015,000-31,530,000-41,630,000······
Income tax expense165,000114,00014,00028,000-196,000-2,793,000r280,316-49,466r1,966,5190
Income from continuing operations···-41,658,000-84,349,000-64,384,000r-16,270,753-35,274,099··
Income from discontinued operations···0-27,000884,000r198,206-4,778,711··
Net income-78,259,000-35,129,000-31,544,000-41,658,000-84,376,000-63,500,000r-16,072,547-40,052,81011,869,823-16,471,603
Net income to common shareholders·-35,129,000-31,544,000····41,700,000r7,772,084-16,471,603
Earnings per share, basic-5.84-7.94-113.58r-1,063.00r···-288.00b100.80b-448.80b
Earnings per share, diluted-5.84-20.91-113.58r-1,063.00r···-288.00b100.80b-448.80b
Earnings per share, basic and diluted·······-288.00b·-448.80b
Weighted average shares, basic13,404,8304,426,149277,72739,202r···144,890b76,708b36,793b
Weighted average shares, diluted13,404,8307,496,389277,72739,202r···144,890b78,145b36,793b
Weighted average shares, basic and diluted·······144,890b·36,793b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-240 reverse split of Dec 2023.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton AVTX · research, not advice